ArticleHealth economics review2025

A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients."

Cesare Aragona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.